Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-004030
Filing Date
2021-02-16
Accepted
2021-02-16 17:15:53
Documents
57
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1176251
2 ex31-1.htm EX-31.1 18677
3 ex31-2.htm EX-31.2 11173
4 ex32-1.htm EX-32.1 4754
5 ex32-2.htm EX-32.2 4756
  Complete submission text file 0001493152-21-004030.txt   4334640

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE btcy-20201231.xml EX-101.INS 677715
7 XBRL SCHEMA FILE btcy-20201231.xsd EX-101.SCH 40077
8 XBRL CALCULATION FILE btcy-20201231_cal.xml EX-101.CAL 45390
9 XBRL DEFINITION FILE btcy-20201231_def.xml EX-101.DEF 205413
10 XBRL LABEL FILE btcy-20201231_lab.xml EX-101.LAB 287588
11 XBRL PRESENTATION FILE btcy-20201231_pre.xml EX-101.PRE 249872
Mailing Address 275 SHORELINE DRIVE SUITE 150 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE SUITE 150 REDWOOD CITY CA 94065 (650) 832-1626
BIOTRICITY INC. (Filer) CIK: 0001630113 (see all company filings)

EIN.: 472548273 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-56074 | Film No.: 21640833
SIC: 3841 Surgical & Medical Instruments & Apparatus